Form 4: Director Linda Gooden Exercises Restricted Stock Units in NeueHealth, Inc.
SEC Form 4 Filing
Director Linda Gooden exercised 10,500 restricted stock units in NeueHealth, Inc. on May 13, 2025, resulting in the acquisition of 10,500 shares of common stock.
Summary
- On May 13, 2025, Linda Gooden, a director of NeueHealth, Inc., exercised 10,500 restricted stock units.
- This transaction resulted in the acquisition of 10,500 shares of NeueHealth's common stock.
- Following the transaction, Gooden directly owns 16,443 shares of NeueHealth common stock.
Sentiment
Score: 5
Explanation: This is a neutral event. It's a routine disclosure of a director exercising vested stock options, which doesn't inherently indicate positive or negative sentiment about the company's prospects.
Industry Context
Form 4 filings are standard disclosures required by the SEC to provide transparency into the transactions of company insiders, such as directors and officers, in their company's stock. This allows investors to monitor insider activity, which can provide insights into management's perspective on the company's value and prospects.
Stakeholder Impact
- The transaction increases the number of outstanding shares of NeueHealth, Inc., which could have a minor dilutive effect on existing shareholders.
Key Dates
| Date | Description |
|---|---|
| 05/13/2025 | Date of transaction: Linda Gooden exercised restricted stock units and acquired common stock. |
| 05/15/2025 | Date of signature on the Form 4 filing. |
Keywords
NeueHealth, Linda Gooden, Director, Restricted Stock Units, Common Stock, Beneficial Ownership, Form 4, SEC
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.